Bristol Myers Reverses Lower Despite Double Phase 3 Win, As A Key Rival Crashes
Key Points:
- Investor’s Business Daily provides information solely for educational and informational purposes, not as investment advice or recommendations to buy or sell securities.
- The data is sourced from what are believed to be reliable providers, but no guarantees are made regarding its accuracy, timeliness, or suitability.
- Past investment performance does not assure future results, and authors may hold positions in the stocks they discuss.
- The information is subject to change without notice, and users should review the Terms of Use for service guidelines.
- Investor’s Business Daily and related trademarks are owned by Investor’s Business Daily, LLC, with real-time price data sourced primarily from Nasdaq Last Sale and other providers.